Management of false-positive rifampicin resistant Xpert MTB/RIF

被引：0

作者：

Beylis, Natalie ^{[1
,2
]}

Ghebrekristos, Yonas ^{[1
,2
]}

Nicol, Mark ^{[1
,3
]}

机构：

[1] Univ Cape Town, Div Med Microbiol, Cape Town, South Africa

[2] Groote Schuur Hosp, Dept Med Microbiol, Natl Hlth Lab Serv, ZA-8000 Cape Town, South Africa

[3] Univ Western Australia, Div Infect & Immun, Sch Biomed Sci, Perth, WA, Australia

来源：

LANCET MICROBE | 2020年 / 1卷 / 06期

关键词：

ASSAY;

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：E238 / E238

页数：1

共 5 条

[1]

Ghebrekristos Y., 2018, THESIS, P69

[2]

Huo F, 2020, OPEN FORUM INFECT DI, V7, P1

[3]

Ngabonziza JCS, 2020, LANCET MICROBE, V1, pE74, DOI 10.1016/S2666-5247(20)30007-0

[4] False-positive rifampin resistant results with Xpert MTB/RIF version 4 assay in clinical samples with a low bacterial load [J].

Ocheretina, Oksana ;

Byrt, Erin ;

Mabou, Marie-Marcelle ;

Royal-Mardi, Gertrude ;

Merveille, Yves-Mary ;

Rouzier, Vanessa ;

Fitzgerald, Daniel W. ;

Pape, Jean W. .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2016, 85 (01) :53-55

[5] Discordance in Xpert® MTB/RIF assay results among low bacterial load clinical specimens in Bangladesh [J].

Sahrin, M. ;

Rahman, A. ;

Uddin, M. K. M. ;

Kabir, S. N. ;

Kabir, S. ;

Houpt, E. ;

Banu, S. .

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2018, 22 (09) :1056-+

← 1 →